Related Experiment Video

Updated: Jun 19, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

[Current clinical trials using new targeted therapies for myeloid leukemia and the research trends]

Jo Ishizawa1, Hideyuki Saya

  • 1Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 29, 2009
PubMed

Insights

Gene expression profiling advances myeloid leukemia understanding and targeted treatments. However, challenges like drug resistance and minimal residual disease persist, prompting research into cancer stem cells.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Genetic aberrations in myeloid leukemia are increasingly understood through gene expression profiling.
  • Targeted therapies like all-trans retinoic acid and imatinib have shown success but are not curative.
  • Drug resistance and minimal residual disease remain significant challenges in myeloid leukemia treatment.

Purpose of the Study:

  • To review current clinical trials of novel targeted therapies for myeloid leukemia.
  • To summarize emerging research trends, including the role of cancer stem cells, in myeloid leukemia.

Main Methods:

  • Review of current clinical trials.
  • Analysis of recent research trends in myeloid leukemia.

Main Results:

  • Targeted therapies have improved outcomes but have not achieved cures.
  • Cancer stem cell concepts offer new insights into leukemia pathobiology.

Conclusions:

  • Despite progress, achieving a cure for myeloid leukemia remains challenging due to resistance and recurrence.
  • Further research into novel targeted therapies and cancer stem cells is crucial for advancing treatment.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...